In contrast to the vector group, the TRIM14 overexpression group experienced a dramatic increase in cell viability (p < 0.05, Figure 3C,D), suggesting that TRIM14 overexpression reduced the response of HCC cells to cisplatin. Here, TRIM14 is linked to hepatocellular carcinoma.